.Three weeks after Roche's Genentech unit ignored an SHP2 inhibitor pact, Relay Therapeutics has val...
.Stoke Therapeutics' Dravet syndrome drug has actually been devoid of a partial hold, removing the m...
.Tough Biotech Partner Editor Gabrielle Masson showed the 2024 lesson of Tough 15 victors on the flo...
.Merck & Co. has actually rapidly recovered some of the prices of its Harpoon Therapies buyout, p...
.After BioMarin administered a spring tidy of its pipe in April, the company has actually made a dec...
.Big Pharmas remain caught to the tip of molecular adhesive degraders. The most up to date provider ...
.A brand new global life scientific research credit report firm, referred to as Symbiotic Capital, h...
.Bristol Myers Squibb is actually axing yet another huge bet coming from the Caforio period, ending ...
.After having a look at period 1 record, Nuvation Biography has made a decision to stop deal with it...
.Zevra Therapeutics' uncommon illness medication seems to be on the pathway to permission this autum...